New research supported by the National Institute on Drug Abuse (NIDA), National Institutes of Health, indicates that people who are trying to end their addiction to marijuana can benefit from a treatment program that combines motivational incentives with cognitive-behavioral therapy. The study is published in the April 2006 issue of the Journal of Consulting and Clinical Psychology.
The federal government, under a new system for regulating natural health products, has approved the herb European pennyroyal as a traditional remedy for the apparent ailment – giddiness.
While migraine headaches are common in teen-agers, they are substantially under-treated, concludes a study of nearly 19,000 12-to-19-year-olds.
Treatment with the antiviral drug valacyclovir, sold as Valtrex, curbs recurrent bouts of genital herpes in pregnant women, a study shows. Moreover, no safety concerns were identified in mothers, fetuses, or neonates exposed to the drug.
Melasma (chloasma or the mask of pregnancy when present in pregnant women) is a tan or dark facial skin discoloration. Although it can affect anyone, melasma is particularly common in women, especially pregnant women and those who are taking oral contraceptives or hormone replacement therapy medications.
Up to 75 percent of the increase in body weight that can occur in patients with type 2 diabetes who are treated with pioglitazone is from water retention, researchers report the journal Diabetes Care. The drug also tends to reduce abdominal fat and blood pressure.
When used with oral contraceptives, the male hair-loss medication finasteride (brand named Propecia) may also help improve hair loss in women, Italian researchers report.
The use of attention deficit drugs rose nearly 19 percent among adults between the ages 20 to 44 in 2005, while the use of these drugs fell 5 percent in children under the age of 10, according to statistics released on Tuesday amid a U.S. review of the drugs’ safety.
Most diagnoses of Alzheimer’s disease are delayed until more than two years after the first symptoms appeared, according to a survey released Tuesday.
Despite its proven efficacy in reducing the risk of stroke in patients with abnormal heart rhythm, the blood thinner warfarin is less commonly given to racial minorities, even though their risk of stroke is higher than that of whites, a new study shows.